Overview
Education: Masters Degree, Biostatistics. Duke University School of Medicine. 2018
Overview: Lexie graduated from the master’s program in biostatistics at Duke in 2018. Over the past five years, she has collaborated with doctors, residents, fellows, and medical students in the Department of Neurosurgery and Pharmacy. Additionally, she is currently working with a faculty member in Surgery to investigate the impact of environmental factors on certain diseases. Lexie has extensive experience in data management with large databases, including MarketScan, HCUP, and CMS Medicare. She has also worked with EHR data and has experience with data extraction from DEDUCE and CRDM. Her statistical interests include longitudinal analysis, mediation analysis, survival analysis and latent class analysis.
Educational Background
Master of Biostatistics
Duke University (Durham, NC, USA) 2016-2018
Bachelor of Science
Mathematics, Statistics
University of Wisconsin-Madison (Madison, WI, USA) 2013-2016
Shandong University (Shandong, China) 2011-2013
Current Appointments & Affiliations
Recent Publications
Evaluation of opioid requirements in mechanically ventilated patients taking buprenorphine/naloxone prior to admission.
Journal Article J Crit Care · September 16, 2025 BACKGROUND: With limited data quantifying opioid requirements based on substance use history, including buprenorphine/naloxone use, optimal pain management for mechanically ventilated patients remains unknown. OBJECTIVE: To compare opioid requirements in m ... Full text Link to item CiteThe association between long-term PM2.5 exposure and risk for pancreatic cancer: an application of social informatics.
Journal Article Am J Epidemiol · March 4, 2025 There is a profound need to identify modifiable risk factors to screen and prevent pancreatic cancer. Air pollution, including fine particulate matter (PM2.5), is increasingly recognized as a risk factor for cancer. We conducted a case-control study using ... Full text Link to item CiteEvaluation of Tacrolimus Concentrations and Clinical Outcomes Between Extended and Immediate Release Formulations in Kidney Transplant.
Journal Article J Pharm Pract · December 2024 Objectives: Tacrolimus remains the mainstay of immunosuppression in kidney transplantation. Understanding the relationship between therapeutic tacrolimus levels and outcomes of acute rejection, patient/graft survival, and tolerability are important. The re ... Full text Link to item CiteRecent Grants
Addressing Bias from Missing Data in EHR Based Studies of CVD
ResearchBiostatistician II · Awarded by National Institutes of Health · 2018 - 2023Chronic Refractory Low Back Pain (CRLBP)
ResearchBiostatistician II · Awarded by Mainstay Medical Ltd. · 2021 - 2023Nevro HF10 Outcomes Analysis
ResearchBiostatistician II · Awarded by Nevro Corp · 2020 - 2022View All Grants